Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Ferreyra, Gabriela A ^a   Elinoff, Jason M ^a   Demirkale, Cumhur Y ^b   Starost, Matthew F ^a   Buckley, Marilyn ^c   Munson, Peter J ^b   Krakauer, Teresa ^c   Danner, Robert L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GAMMA INTERFERON; IMMUNOPROTEASOME; INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 7; PROTEASOME; PROTEIN ZBP1; RNA; STAPHYLOCOCCUS ENTEROTOXIN B; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CXCL11 GENE; DNA DAMAGE; DNA REPAIR; ENDOPLASMIC RETICULUM STRESS; GENE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC PROCEDURES; GENETIC TRANSCRIPTION; HEART; HERC6 GENE; INNATE IMMUNITY; IRF1 GENE; IRF8 GENE; IRGM1 GENE; KIDNEY; LETHALITY; LIVER; LUNG; MACROPHAGE; MALE; METABOLIC STRESS; MICROARRAY ANALYSIS; MONOCYTE; MOUSE; NONHUMAN; PARP12 GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SPLEEN; STAT1 GENE; T LYMPHOCYTE; UPREGULATION; XAF1 GENE; ZBP1 GENE;

ADMINISTRATION, INTRANASAL; ANIMALS; ENTEROTOXINS; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; IMMUNITY, INNATE; INJECTIONS, INTRAPERITONEAL; INTERFERON REGULATORY FACTORS; KIDNEY; LEUKOCYTES, MONONUCLEAR; LIVER; LUNG; MALE; MICE; MYOCARDIUM; PROMOTER REGIONS, GENETIC; SHOCK, SEPTIC; SPLEEN; SURVIVAL ANALYSIS; TRANSCRIPTOME;

EID: 84895800371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088756     Document Type: Article

References (84)

1. Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, et al. (1980) Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303: 1436-1442.
2. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, et al. (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1-7. (Pubitemid 19170377)
3. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, et al. (1991) Endotoxemia in human septic shock. Chest 99: 169-175.
4. Tanaka H, Mituo T, Yukioka T, Matsuda H, Shimazaki S, et al. (1995) Comparison of hemodynamic changes resulting from toxic shock syndrome toxin-1-producing Staphylococcus aureus sepsis and endotoxin-producing gram-negative rod sepsis in patients with severe burns. J Burn Care Rehabil 16: 616-621.
5. Drake CG, Kotzin BL (1992) Superantigens: biology, immunology, and potential role in disease. J Clin Immunol 12: 149-162.
6. Lappin E, Ferguson AJ (2009) Gram-positive toxic shock syndromes. Lancet Infect Dis 9: 281-290.
7. McCormick JK, Yarwood JM, Schlievert PM (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55: 77-104. (Pubitemid 32978101)
8. Bhardwaj N, Young JW, Nisanian AJ, Baggers J, Steinman RM (1993) Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J Exp Med 178: 633-642. (Pubitemid 23218212)
9. Carlsson R, Fischer H, Sjogren HO (1988) Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol 140: 2484-2488.
10. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, et al. (1989) Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A 86: 8941-8945. (Pubitemid 20010341)
11. Fraser JD, Newton ME, Weiss A (1992) CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J Exp Med 175: 1131-1134.
12. Krakauer T (1994) Costimulatory receptors for the superantigen staphylococcal enterotoxin B on human vascular endothelial cells and T cells. J Leukoc Biol 56: 458-463.
13. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248: 705-711.
14. Stevens DL (1996) The toxic shock syndromes. Infect Dis Clin North Am 10: 727-746.
15. Madsen JM (2001) Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med 21: 593-605.
16. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Lee AC, et al. (1982) An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome. Ann Intern Med 96: 969-971. (Pubitemid 12088913)
17. Eriksson BK, Andersson J, Holm SE, Norgren M (1999) Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 180: 410-418. (Pubitemid 30256323)
18. Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, et al. (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37: 333-340. (Pubitemid 36976489)
19. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, et al. (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 28: 800-807. (Pubitemid 29169419)
20. Krakauer T (2010) Therapeutic down-modulators of staphylococcal superanti-gen-induced inflammation and toxic shock. Toxins (Basel) 2: 1963-1983.
21. Norrby-Teglund A, Pauksens K, Norgren M, Holm SE (1995) Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis 27: 125-130.
22. Seishima M, Kato G, Shibuya Y, Matsukawa S (2009) Cytokine profile during the clinical course of toxic shock syndrome. Clin Exp Dermatol 34: e632-635.
23. Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, et al. (2002) Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166: 1197-1205. (Pubitemid 35222596)
24. Dinges MM, Schlievert PM (2001) Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect Immun 69: 7169-7172. (Pubitemid 32995481)
25. Krakauer T (1999) Immune response to staphylococcal superantigens. Immunol Res 20: 163-173.
26. Roy CJ, Warfield KL, Welcher BC, Gonzales RF, Larsen T, et al. (2005) Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect Immun 73: 2452-2460. (Pubitemid 40470848)
27. Stiles BG, Bavari S, Krakauer T, Ulrich RG (1993) Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun 61: 5333-5338. (Pubitemid 23353916)
28. Sarawar SR, Blackman MA, Doherty PC (1994) Superantigen shock in mice with an inapparent viral infection. J Infect Dis 170: 1189-1194. (Pubitemid 24328622)
29. Nagaki M, Muto Y, Ohnishi H, Yasuda S, Sano K, et al. (1994) Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 106: 450-458. (Pubitemid 24041223)
30. Chen JY, Qiao Y, Komisar JL, Baze WB, Hsu IC, et al. (1994) Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun 62: 4626-4631. (Pubitemid 24302000)
31. Huzella LM, Buckley MJ, Alves DA, Stiles BG, Krakauer T (2009) Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: a new mouse model. Res Vet Sci 86: 241-247.
32. Rajagopalan G, Iijima K, Singh M, Kita H, Patel R, et al. (2006) Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun 74: 1284-1296. (Pubitemid 43185568)
33. Komisar JL, Weng CF, Oyejide A, Hunt RE, Briscoe C, et al. (2001) Cellular and cytokine responses in the circulation and tissue reactions in the lung of rhesus monkeys (Macaca mulatta) pretreated with cyclosporin A and challenged with staphylococcal enterotoxin B. Toxicol Pathol 29: 369-378. (Pubitemid 32587454)
34. Mattix ME, Hunt RE, Wilhelmsen CL, Johnson AJ, Baze WB (1995) Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol 23: 262-268.
35. Savransky V, Rostapshov V, Pinelis D, Polotsky Y, Korolev S, et al. (2003) Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B. Toxicol Pathol 31: 373-378. (Pubitemid 36897233)
36. Barb JJ, Munson PJ (2009) Mathematical and Statistical Computing Lab: The MSCL Analyst's Toolbox.
37. Galiveti CR, Rozhdestvensky TS, Brosius J, Lehrach H, Konthur Z (2010) Application of housekeeping npcRNAs for quantitative expression analysis of human transcriptome by real-time PCR. RNA 16: 450-461.
38. Taylor RT, Lubick KJ, Robertson SJ, Broughton JP, Bloom ME, et al. (2011) TRIM79alpha, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 10: 185-196.
39. Wieland S, Thimme R, Purcell RH, Chisari FV (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101: 6669-6674. (Pubitemid 38586032)
40. Li H, Gade P, Xiao W, Kalvakolanu DV (2007) The interferon signaling network and transcription factor C/EBP-beta. Cell Mol Immunol 4: 407-418.
41. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, et al. (2013) STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41: D808-815.
42. Rusinova I, Forster S, Yu S, Kannan A, Masse M, et al. (2013) Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 41: D1040-1046.
43. Krakauer T, Buckley M, Issaq HJ, Fox SD (2010) Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo. Antimicrob Agents Chemother 54: 1125-1131.
44. Severa M, Coccia EM, Fitzgerald KA (2006) Toll-like receptor-dependent and - independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J Biol Chem 281: 26188-26195. (Pubitemid 44401826)
45. Doody GM, Care MA, Burgoyne NJ, Bradford JR, Bota M, et al. (2010) An extended set of PRDM1/BLIMP1 target genes links binding motif type to dynamic repression. Nucleic Acids Res 38: 5336-5350.
46. Schlievert PM (1986) Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1: 1149-1150.
47. Descloux E, Perpoint T, Ferry T, Lina G, Bes M, et al. (2008) One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis 27: 37-43. (Pubitemid 350197878)
48. DeVries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, et al. (2011) Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. PLoS One 6: e22997.
49. Chowdhary VR, Tilahun AY, Clark CR, Grande JP, Rajagopalan G (2012) Chronic exposure to staphylococcal superantigen elicits a systemic inflammatory disease mimicking lupus. J Immunol 189: 2054-2062.
50. Plaza R, Rodriguez-Sanchez JL, Juarez C (2007) Staphylococcal enterotoxin B in vivo modulates both gamma interferon receptor expression and ligandinduced activation of signal transducer and activator of transcription 1 in T cells. Infect Immun 75: 306-313. (Pubitemid 46047906)
51. Tilahun AY, Holz M, Wu TT, David CS, Rajagopalan G (2011) Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome. PLoS One 6: e16764.
52. Goenka S, Boothby M (2006) Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor. Proc Natl Acad Sci U S A 103: 4210-4215.
53. Mehrotra P, Riley JP, Patel R, Li F, Voss L, et al. (2011) PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation. J Biol Chem 286: 1767-1776.
54. Zhu M, John S, Berg M, Leonard WJ (1999) Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. Cell 96: 121-130.
55. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, et al. (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505. (Pubitemid 47123520)
56. Wang Z, Choi MK, Ban T, Yanai H, Negishi H, et al. (2008) Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci U S A 105: 5477-5482. (Pubitemid 351753888)
57. Cho SH, Goenka S, Henttinen T, Gudapati P, Reinikainen A, et al. (2009) PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells. Blood 113: 2416-2425.
58. Hakme A, Huber A, Dolle P, Schreiber V (2008) The macroPARP genes Parp-9 and Parp-14 are developmentally and differentially regulated in mouse tissues. Dev Dyn 237: 209-215.
59. O'Neill LA (2009) DNA makes RNA makes innate immunity. Cell 138: 428-430.
60. Stetson DB, Medzhitov R (2006) Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24: 93-103. (Pubitemid 43077203)
61. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
62. Atasheva S, Akhrymuk M, Frolova EI, Frolov I (2012) New PARP gene with an anti-alphavirus function. J Virol 86: 8147-8160.
63. Leung A, Todorova T, Ando Y, Chang P (2012) Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm. RNA Biol 9: 542-548.
64. Fang TC, Schaefer U, Mecklenbrauker I, Stienen A, Dewell S, et al. (2012) Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J Exp Med 209: 661-669.
65. Trinchieri G (2010) Type I interferon: friend or foe? J Exp Med 207: 2053- 2063.
66. Vitour D, Meurs EF (2007) Regulation of interferon production by RIG-I and LGP2: a lesson in self-control. Sci STKE 2007: pe20.
67. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-Imediated antiviral responses to single-stranded RNA bearing 59-phosphates. Science 314: 997-1001. (Pubitemid 44749946)
68. Oudshoorn D, van Boheemen S, Sanchez-Aparicio MT, Rajsbaum R, Garcia-Sastre A, et al. (2012) HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells. PLoS One 7: e29870.
69. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, et al. (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70: 1032-1060. (Pubitemid 44958263)
70. Castelli J, Wood KA, Youle RJ (1998) The 2-5A system in viral infection and apoptosis. Biomed Pharmacother 52: 386-390. (Pubitemid 29356448)
71. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, et al. (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480: 379-382.
72. York IA, Chang SC, Saric T, Keys JA, Favreau JM, et al. (2002) The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 3: 1177-1184. (Pubitemid 35469702)
73. Wang J, Maldonado MA (2006) The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol 3: 255-261.
74. Ebstein F, Lange N, Urban S, Seifert U, Kruger E, et al. (2009) Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int J Biochem Cell Biol 41: 1205-1215.
75. Temajo NO, Howard N (2012) The viral enterprises in autoimmunity: conversion of target cells into de novo APCs is the presage to autoimmunity. Autoimmun Rev 11: 653-658.
76. Yang Z, Gagarin D, St Laurent G 3rd, Hammell N, Toma I, et al. (2009) Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome. Arterioscler Thromb Vasc Biol 29: 1213-1219.
77. Brogan PA, Shah V, Klein N, Dillon MJ (2004) Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Arthritis Rheum 50: 589-597. (Pubitemid 38202231)
78. Huys L, Van Hauwermeiren F, Dejager L, Dejonckheere E, Lienenklaus S, et al. (2009) Type I interferon drives tumor necrosis factor-induced lethal shock. J Exp Med 206: 1873-1882.
79. Martin FJ, Gomez MI, Wetzel DM, Memmi G, O'Seaghdha M, et al. (2009) Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest 119: 1931-1939.
80. Krakauer T, Buckley MJ, Huzella LM, Alves DA (2009) Critical timing, location and duration of glucocorticoid administration rescue mice from superantigen-induced shock and attenuate lung injury. Int Immunopharmacol 9: 1168-1174.
81. Cao W, Manicassamy S, Tang H, Kasturi SP, Pirani A, et al. (2008) Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol 9: 1157-1164.
82. Saemann MD, Haidinger M, Hecking M, Horl WH, Weichhart T (2009) The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant 9: 2655-2661.
83. Weichhart T, Saemann MD (2009) The multiple facets of mTOR in immunity. Trends Immunol 30: 218-226.
84. Schmitz F, Heit A, Dreher S, Eisenacher K, Mages J, et al. (2008) Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur J Immunol 38: 2981-2992.